Peer Review History
| Original SubmissionApril 1, 2023 |
|---|
|
PONE-D-23-07935Time to Recovery from Necrotizing Entrocolites and Its Determinant Factors among Hospitalized Neonates in Bahir Dar, Ethiopia: A Retrospective Follow up Study, 2022.PLOS ONE Dear Dr. Sisay Shewasinad Yehualashet Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 30 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Sanjoy Kumer Dey, M.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: "no source of funding" At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in your Competing Interests section: "authors have no competing interests" Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 6. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical. 7. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you, authors, for bringing up this essential study issue in your scholarly work. The results are valuable for practice and have a bearing on public health. I do have some major and minor concerns, though. Major concern 1. You determine the recovery of baby from NEC by reaching full calorie intake (150 ml/kg or 180 ml/kg) and limiting the follow-up period to 14 days. The standard duration of therapy for NEC ranges from 7 to 14 days and also in some cases like Surgical NEC, prematurity, Stage III PNA it may take longer than that to achieve complete feeding. Therefore, the majority of the baby may be ignored or recruited to censor, especially in stage II and stage III NEC babies. This could lead to an incorrect conclusion. I am not clear why do you want to restrict the follow-up date? Minor comments 1. You stated that recovery time is slightly lower in line 43 of your conclusion. What does "slightly lower" mean? And what criteria do you use to determine whether something is lower or higher? It is better to describe in faster or prolonged. 2. If your finding implies faster recovery time, your recommendation may be better relate with enhancing or strengthening the existing practice. 3. Your paper's introduction section is lengthy. Please keep it brief and to the point by combining related results into a single paragraph. 4. You claimed that respiratory assistance was used to help those with respiratory failure in Line 254. You ought to state Respiratory distress, in my opinion. Furthermore, What about resuscitation considering that around 30% of babies have PNA? 5. Line 262 median follow-up time was 10 days. Remove it because it doesn't convey any vital information. Instead, it is enough to describe the incidence density rate and median recovery time. 6. Be sure that the proportional hazard assumption is satisfied, unless using other parametric models is preferable. The PNA KM curve and NEC stage seem to contradict the assumption of hazard proportionality. 7. Make the necessary corrections in Table 4 (Breast Milk), and in Table 6 (Reinitiating Day of Feeding Reference =1), Line 340 (Incidence Rate), Line 345 (Babies or Newborns), 8. Please include some standards or scientific support for your discussion section beyond comparing your findings to those of others. Also, summarize comparable ideas or findings into a single paragraph. 9. Avoid redundancy of ideas. For instance, lines 264 and 285; 271 and table 5; 299 and lines 360–362... Reviewer #2: Title: Time to Recovery from Necrotizing Enterocolites and Its Predictors among Hospitalized Neonates in Bahir Dar, Ethiopia: A Retrospective Follow up Study. Abstract: Line 39-43- All of these predictors have a weak strength of association, do you think, based on such strength your recommendation will be acceptable? Line 46-49: How can assured that they were not give attention? Your recommendation better to be modified based on your findings, but not based on your real facts. Introduction: General comment: It didn’t show the gap that the findings of this research will fill. Previous works of literatures were not dig out well, poor literature review you did. The general write up was not good including the language, better to be modified. The coherence of the write was not good, better to be revised. Finally, better to precisely and coherently written with adequate literature review. Methods: Line 160-64: I think such type of sample size determination formula is not appropriate for time to event data. I am eager to hear your justification why you are using margin of error=3??? Line 204: Are they professionals working at the study site? Line 227: What are the method used for assumption checking for independent variables and when we accept the variable for regression or at least by what method the variable should fulfil the assumption to use cox proportional Hazard regression? Line 235: Could you think this graph showed the model was fitted? Better to see or clean your data again and again before fitting the model and adequacy checking. Result: Line 259: Table 2: In Your statement of justification early age of neonate is risk factors, but here there is less risk difference. How do you justify it? Where did you get the age of the mother, hence it is a chart review for neonates and if there is the chance to get maternal data, why not include maternal related other variables? Table 3: What is the prevalence of preterm birth in Ethiopia? Have you appreciate your descriptive statistics here? You know that preterm neonates are more prone to develop NEC than others if so is it comparable? Line 283 and 287: What is the cumulative survival probability? And Did the service provision given at these hospitals reduce the neonatal mortality due to NEC??? Why such large proportion of neonates were died after admission? Have got insights regarding such death? Line 307: Why most of the neonate were died after admission??? The NEC or the poor service delivery system??? Better to incorporate in your discussion such peculiar findings. Figure 4: Did the graph fulfil the assumption? Did this graph fulfil the assumption statistically? Better to include statistically methods of assumption checking in addition to graphical methods? Table 6: PNA is Well Known factor for NEC. Are you sure not having PNA is a cause for NEC??? Needs detail discussion. Most of your statistically significant variables had weak strength of association. How can you interpreted it? Do you think based on this findings recommendation is acceptable? Discussion: General comments: your discussion is poor even though your findings are peculiar including your write up, coherence and interpretation and implication. Revised your discussion. Line 361: If it reported incidence of survival, which was censored, not comparable with your findings since you are reported incidence proportion of recovery, which was event. Line 372: Do you think sample size difference a justification for result difference? What does sampling distribution mean? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-23-07935R1Time to Recovery from Necrotizing Enterocolites and Its Predictors among Hospitalized Neonates in Bahir Dar, Ethiopia: A Retrospective Follow up Study, 2022PLOS ONE Dear Dr. Yehualashet, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 29 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Sanjoy Kumer Dey, M.D Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Time to Recovery from Necrotizing Entrocolites and Its Determinant Factors among Hospitalized Neonates in Bahir Dar, Ethiopia: A Retrospective Follow up Study, 2022 Dear editorial team: Thank you very much for giving me the opportunity to review this manuscript It is well known that NEC is one of the most common devastating, life-threatening, acquired gastrointestinal disorder in neonates. Despite this fact, why you are interested in studying time to recovery from NEC? Do you think that time is a big deal? Why you failed to deal about treatment outcome or survival status or something else? From the abstract section: you should show the gaps and why you are going to deal about time to recovery from NEC? The information presented from the system and the main document is different. So, which abstract is presented for review? Reference 4 is missed Background: Long sentence with poor grammar typographical or grammatical errors should be corrected. Most paragraphs are constructed with a single sentence and more complicated to understand. I suggest professional help in revising this manuscript. The flow of idea from one paragraph to the other paragraph is unrelated and difficult to understand. Most of the idea presented in each paragraph is unrelated to the study objectives. The overall incidence and /or prevalence of NEC is not stated clearly. The gap/why this study was carried out is not also described? Data extraction period presented from the system and the main document is different. What is the reason for this discrepancy? Why did you calculate sample size using single population mean rather than double population? In majority of health science studies we use tolerable margin of error (d=5%) but you use 3%. Could you explain your justification? The sample size calculation is still vague. What is the source/study population? What is the inclusion and exclusion criterion? If the data was collected by neonatal nurse, how do you handle different types of bias? Why do you calculate median time instead of mean time to determine survival time? Abbreviation/acronym should be written in full sentence during the first appearance. Eg FHCSH, TGSTH, AH, HMD, PNA, RDS, and GA Discussion it needs major revision First please remove statements described in the first two line of discussion section When you write discussion, first you should discuss on the recovery time from NEC on similar studies conducted across the globe and put your scientific justification for the possible discrepancy if any then you can discuss on each explanatory variables starting from the local to global. The statement presented on line number 346 is not similar/comparable with the idea stated on line number 347-49. So, it needs revision. The statement described from line number 350-353 is not clear and is not presented well. You are not expected to restate the results of the study rather comparing your study result with the other previously conducted researches and put the evidence for variations. The possible reason raised during discussion is not sound and persuasive. So, it needs a major modification. The discussion part is not written adequately and you should write starting from local to global unlike literature review from global to local. In order to write a good discussions, you should search exhaustively similar studies done a broad and nationally. unless it becomes shallow. You are also expected to discuss on the implications of the findings in context of existing research. Based on your findings, you should write appropriate recommendation. Limitation of the study is not written? Why ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
PONE-D-23-07935R2Time to Recovery from Necrotizing Enterocolites and Its Predictors among Hospitalized Neonates in Bahir Dar, Ethiopia: A Retrospective Follow up Study, 2022PLOS ONE Dear Dr. Yehualashet, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 10 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Sanjoy Kumer Dey, M.D Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: Specific and detailed comments to the authors were attached as a word file to the system. Thus, I don't think that it's appropriate to repeat it here. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: Yes: Migbar Sibhat ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 3 |
|
PONE-D-23-07935R3Time to Recovery from Necrotizing Enterocolitis and Its Predictors among Neonates Admitted to Neonatal Intensive Care Unitin Bahir Dar, Ethiopia: A Retrospective Follow up Study, 2022PLOS ONE Dear Dr. Yehualashet, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 10 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
We look forward to receiving your revised manuscript. Kind regards, Sanjoy Kumer Dey, M.D Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: Title: Time to Recovery from Necrotizing Enterocolitis and Its Predictors among Neonates Admitted to Neonatal Intensive Care Unitin Bahir Dar, Ethiopia: A Retrospective Follow up Study, 2022 (R2) I would like to thank the editor for offering this opportunity to review the revised version of this work. The authors tried to partially address the comments raised in the previous review session. I appreciate the efforts devoted so far. However, still there are fundamental issues that are not yet moderated, or some unsatisfactory responses forwarded. Without addressing those issues exhaustively, the validity of the study findings will be threatened and not worth for publication. Major comments: 1. 1.1. The sample size issue remains the major concern in this manuscript. The authors could not forward statistically convincing and satisfactory justification to the previously raised concerns. It is true that single population formula can be applied if there are not studies conducted to fulfill the parameters required to apply the standard methods of sample size calculation for the given study type. However, since the authors were working on dichotomous outcome variable and categorical data, it’s completely unacceptable to use population mean. Population proportion should be the only option in such scenarios if it’s mandatory to use single population formula. How could you apply linear assumptions and parameters to estimate for binary outputs? I doubt the reproducibility of the finding since the applied sample size is one of the major factors that influence the generalizability/representativeness of the study findings. 1.2. The other thing is that “time to reach full enteral feeding” might not necessarily imply NEC recovery since NEC is not the orphan determinant of enteral feeding. I.e neonates without NEC might also encounter such problems. Inability to full enteral feeding could not be generalized to NEC since it could also be due to other causes. 2. The other major concern was that the authors could not provide clear diagnostic criteria applied to identify NEC in their study. The scientific definition provided was vague and non-specific. The diagnosis set by physicians for treatment purpose could not be directly applied for the research purpose. Rather the authors should set specific and clear criteria and differentiate NEC cases during data extraction based on the predetermined criteria (operational definition) from the charts (patient records). You declared the newborn when you got which radiorgraphic findings, which symptoms and signs? as well as how many of those criteria fulfilled? 3. Figure 1 (KM-curve): Wrong graph label and interpretation! 3.1. The x-axis label (recovery time from NEC) is incorrect and that shoud be replaced with “analysis time”. Because the analysis time incorporates the time at risk for both recovered and censored cases (hence could not be exclusively considered as recovery time). 3.2. Line 219-21: “The overall Kaplan Meire estimates identified that the probability recovery of neonates admitted with NEC was zero in the first 3 days of follow up…”. This statement is completely wrong. Any individual who understand English language could not interpret it as the authors intend to infer, NEVER! The authors made incorrect interpretation of the KM-graph. This is because the authors understand the statistical science, but they miss the nature of the event of interest in their own study. Researchers and statisticians need to interpret findings based on the nature of the outcome/event of interest being investigated. Correct interpretation of the finding in the Figure 1: As we note from the figure (KM-curve), the survival probability (probability of recovery) remains 1 (100%) in the first 3 days, after which it slowly dropped down stepwise as the survival time increased from 0 to 14 days. This means in the first three days; every neonate has the probability to recover from NEC. 4. 4.1. Most of the rationales stated in the discussion section of this manuscript were vague and non-specific to NEC. Majority of the explanations for the discrepancies were general views such as socio-economic, study design, setting difference, infrastructure, quality of healthcare services and so on. However, all these concepts were not declared to have direct association with NEC and the authors failed to cite the sources of such arguments if available. 4.2. Citation of references for the scientific justifications is required yet and it could not be bypassed at all. As you already stated, the purpose of the discussion section is to interpret the results and provide an analysis of the findings in the context of existing knowledge and theories. Please cite those existing knowledge and theories that could support your justification! Note: Research discussion should address four major points: result interpretation, comparison, justification of discrepancies and explanation of associations, as well as implication to clinical practice. The discussion should enrich with tangible evidences and explanations so that it can be trustworthy to the scientific community. However, if it is solely written based on authors’ opinion and thoughts without tangible and citable sources, it could not be considered as scientific paper. It could be a fiction rather! Minor comments: 1. Line 69-73: Please remove the first two statements of from the last paragraph of the “Introduction” section. I wonder why the authors just incorporate those statements, while it’s known that NEC is a different concept to asphyxia and RDS. 2. The authors tried to moderate the gap statement. Nevertheless, the manuscript will be benefited if the authors incorporate data related to the difference in survival rate, risk/occurrence of complications and other adverse events between longer vs shorter recovery time. For instance, neonates who recovered fast from NEC might have good prognostic outcome in terms of cognitive function, growth and development, and other long term consequences (NB: This is just an instance). 3. Line 157-58 & Line 162-63: Contradicting ideas presented yet again. Schoenfield Residuals test is an assumption (PH-assumption) test and you stated in the earlier statement as “an assumption test” and later as a “model fitness” test. Please avoid such statistical ambiguities. 4. Line 163-65: Where is the Cox-Snell residual graph? Please provide the graph and cite in “Line 165” as figure file (e.g. Fig. 1). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: Yes: Migbar Sibhat ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 4 |
|
Time to Recovery from Necrotizing Enterocolitis and Its Predictors among Neonates Admitted to Neonatal Intensive Care Unitin Bahir Dar, Ethiopia: A Retrospective Follow up Study, 2022 PONE-D-23-07935R4 Dear Dr. Yehualashet, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sanjoy Kumer Dey, M.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: The authors addressed majority of the comments forwarded in the previous round. The only concern that is not yet convincing is the suitableness of the sample size calculation formula used in this study. However, I think it will not significantly affect the validity of findings and conclusions forwarded so far. Hence, I recommend the manuscript to be accepted for publication after minor edition tasks and language improvements. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: Yes: Migbar Mekonnen Sibhat ********** |
| Formally Accepted |
|
PONE-D-23-07935R4 PLOS ONE Dear Dr. Yehualashet, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sanjoy Kumer Dey Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .